Impact of pro-atrial natriuretic peptide in atrial fibrillation and stroke

被引:0
|
作者
Roever, Leonardo [1 ]
Resende, Elmiro Santos [1 ]
Roerver-Borges, Anaisa Silva [2 ]
机构
[1] Univ Fed Uberlandia, Dept Clin Res, Uberlandia, MG, Brazil
[2] IMEPAC, Master Inst Educ President Antonio Carlos, Araguari, Brazil
关键词
HEART-FAILURE; RISK STRATIFICATION; MR-PROANP; ASSOCIATION; ATHEROSCLEROSIS; ADRENOMEDULLIN; PREDICTION; BIOMARKERS; STIFFNESS;
D O I
10.1177/2047487317707832
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1239 / 1241
页数:3
相关论文
共 50 条
  • [41] Characterization of the corin-mediated pro-atrial natriuretic peptide processing in murine cardiac myocytes
    Wu, F
    Yan, W
    Pan, JL
    Morser, J
    Wu, QY
    CIRCULATION, 2001, 104 (17) : 172 - 173
  • [42] Plasma levels of N-terminal peptide of pro-atrial natriuretic peptides in myoskeletal injuries
    Onuoha, GN
    Alpar, EK
    REGULATORY PEPTIDES, 2001, 99 (01) : 17 - 20
  • [43] Midregional pro-atrial natriuretic peptide, an important member of the natriuretic peptide family: potential role in diagnosis and prognosis of cardiovascular disease
    Idzikowska, Karolina
    Zielinska, Marzenna
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2018, 46 (08) : 3017 - 3029
  • [44] Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia
    Krueger, Stefan
    Papassotiriou, Jana
    Marre, Reinhard
    Richter, Klaus
    Schumann, Christian
    von Baum, Heike
    Morgenthaler, Nils G.
    Suttorp, Norbert
    Welte, Tobias
    INTENSIVE CARE MEDICINE, 2007, 33 (12) : 2069 - 2078
  • [45] N-terminal pro-atrial natriuretic peptide and exercise prescription in patients with myocardial infarction
    Ikeda, Nahoko
    Yasu, Takanori
    Nishikimi, Toshio
    Nakamura, Tomohiro
    Kubo, Norifumi
    Kawakami, Masanobu
    Momomura, Shin-ichi
    Saito, Muneyasu
    REGULATORY PEPTIDES, 2007, 141 (1-3) : 154 - 158
  • [46] Midregional pro-atrial natriuretic peptide: a novel marker of myocardial fibrosis in patients with hypertrophic cardiomyopathy
    Elif Elmas
    Christina Doesch
    Stephan Fluechter
    Miriam Freundt
    Christel Weiss
    Siegfried Lang
    Thorsten Kälsch
    Dariush Haghi
    Jana Papassotiriou
    Jan Kunde
    Stefan O. Schoenberg
    Martin Borggrefe
    Theano Papavassiliu
    The International Journal of Cardiovascular Imaging, 2011, 27 : 547 - 556
  • [47] Is mid-regional pro-atrial natriuretic peptide (MRproANP) an accurate marker of bacteremia in pyelonephritis?
    Guinard-Barbier, Solweig
    Grabar, Sophie
    Chenevier-Gobeaux, Camille
    Quinquis, Laurent
    Schmidt, Jeannot
    Kierzek, Gerald
    Guerin, Sylvie
    Hausfater, Pierre
    Bernot, Bruno
    Brun, Patrick
    Gayet, Alberic
    Casalino, Enrique
    Andreotti, Christophe
    Renaud, Bertrand
    Claessens, Yann-Erick
    BIOMARKERS, 2011, 16 (04) : 355 - 363
  • [48] Mitregionales Pro-Atrial Natriuretic Peptide (MRpro-ANP) during the postpartural and postnatal Adaptation
    Benzing, J.
    Wellmann, S.
    Szinnai, G.
    Hegi, L.
    Admaty, D.
    Cippa, G.
    Beinder, E.
    Morgenthaler, N.
    Haagen, U.
    Bucher, H. U.
    Buehrer, C.
    Lapaire, O.
    KLINISCHE PADIATRIE, 2010, 222 : S86 - S87
  • [49] Usefulness of mid regional pro-atrial natriuretic peptide in the exacerbations of chronic obstructive pulmonary disease
    Lacoma, Alicia
    Prat, Cristina
    Andreo, Felipe
    Lores, Luis
    Latorre, Irene
    Perez, Miguel
    Ruiz-Manzano, Juan
    Ausina, Vicente
    Dominguez, Jose
    CLINICA CHIMICA ACTA, 2011, 412 (5-6) : 470 - 475
  • [50] Pro-Atrial Natriuretic Peptide In Vitro and In Vivo Normal Canines: A Selective Renal Enhancing Therapeutic
    Ichiki, Tomoko
    Ingrid, Anderson A.
    Huntley, Brenda K.
    Sangaralingham, S. Jeson
    Harty, Gail J.
    Sandberg, Sharon M.
    Heublein, Denise M.
    Burnett, John C., Jr.
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (08) : S27 - S27